DHA Oil Encapsulated DHA Powder Nutrition Enhancer

Min.Order: 100

Product origin: Qingdao, Shandong, China

Infringement complaint:

Complaint

US$ 1 ~ 40

Description

DHA Oil Encapsulated DHA Powder Nutrition Enhancer

Introduction:

DHA Encapsulated Powder contains: Docosahexanoic acid oil, produced from the fermentation of algal specie Schizochytrium sp.(DHA O40),Lactose, Whey protein powder, Anhydrous cream, Food additive ( Sodium citrate, Sodium ascorbate, Phosphatide, Tricalcium phosphate, Mono-and distearates of fatty acids, Ascorbyl palmitate, Vitamin E ).
Docosahexaenoic acid (DHA) belongs to the family of omega-3 long-chain polyunsaturated fatty acids that is a primary structural component of the human brain, cerebral cortex, skin, and retina.
The long-chain omega-3 fatty acid is found in cell membranes throughout the body and helps to transmit messages between nerves.
DHA algal oil is extracted from Schizochytrium which is cultivated and fermented in a well-controlled environment.Pure, Non-GMO, solvent-free, and natural triglyceride form.
Without fishy smell and has lower heavy metal contaminations than fish oil from the ocean.
Sustainable, plant-based source, without impact on the marine ecosystem and no pressure on fish resources

DHA Oil Encapsulated Powder Parameters:

Test Items	Specification	Test Method	Result
Taste and Smell	Typical smell and taste	IQC001CH	Pass
Statement	Dry free flowing powder, no blcok	IQC001CH	Pass
color	White to off white	IQC001CH	Pass
Solubility	25-45°C water or milk to form a stable emulsion. No sedimentation	IQC001CH	Pass
Impurities	No visual impurities	IQC001CH	Pass
DHA Content (By C₂₂H₃₂O₂ Triglyceride) %	≥10.0 ≥20.0	IQC001CH	≥10.0 ≥20.0
EPA Content %	£1.0	GB 5009.168	0.1
Moisture %	£5.0	GB 5009.3	3.6
Ash %	£5.0	GB 5009.4	3.3
Surface Oil %	£1.0	IQC004CH	0.2
Peroxide Value (mmol/Kg)	£2.5	IQC005CH	0.04
Tapped Density (g/cm³)	0.4-0.6	ISO 8967:2005	0.5
Trans-Fatty Acid %	£1.0	GB 5009.257	0.3
Aflatoxin M1 (ug/Kg)	£0.5	GB 5009.24	<0.075
Total Arsenic (As) (mg/Kg)	£0.1	GB 5009.76	N.D.
Pb (mg/Kg)	£0.1	GB 5009.75	N.D.
Hg (mg/Kg)	£0.05	GB 5009.17	N.D.
Total Plate Count (CFU/g)	n=5,c=2,m=500,M=1000	GB 4789.2	25,20,15,15,10
Coliform (CFU/g)	n=5,c=2,M=10	GB 4789.3	<10, <10, <10, <10, <10
Coliform (MPN/g)	n=5,c=2,M=0.3	GB 4789.3	<0.3, <0.3, <0.3, <0.3, <0.3,
Mold & Yeast (CFU/g)	n=5,c=2,M=50	GB 4789.15	<10, <10, <10, <10, <10
Salmonella (/25g)	N.D.	GB 4789.4	NG, NG, NG, NG, NG
Enterobacter sakazakii (/100g)	N.D.	GB 4789.40	NG, NG, NG, NG, NG
Staphylococcus Aureus (/25g)	N.D.	GB 4789.10	NG, NG, NG, NG, NG
Conslusion	Meet GB26687-2001 National Standard and Q/HXH 002S-2021 Company Standard

Function:

Higher DHA levels at birth are associated with better childhood neurodevelopmental health, while lower DHA levels were linked to higher rates of autism spectrum disorders and attention-deficit/hyperactivity disorder.
Help Brain development.
Help early visual acuity
DHA supplementation during the later weeks of pregnancy is also linked to a decreased risk of early preterm labor.
In the first 6 months of life, DHA is especially important for the development of the nervous system.
May help protect against age-related cognitive decline.
May help protect against depression.
Might improve outcomes in people with heart disease.
Consuming high ratios of DHA help with depression, mood swings, bipolar symptoms, poor memory, cognitive decline, and other brain-based disorders.